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Abstract
Background: Depression is associated with risk for chronic
disease, though its relationship with infectious diseases is
less understood. Depression may modify the clinical outcomes of patients with infectious diseases such as influenza
via its association with inflammation. The objective of this
study was to evaluate the relationships between depression
and clinical outcomes in non-elderly adults with influenza infection.

Results: A total of 44,292 patients were included, 12% with
depression. After adjustment for confounding, non-elderly influenza patients with depression had a 3.8% decreased risk
of a severe disease (95% confidence interval [CI] 1.9–5.7;
P <0.001), no difference in length of stay (hazard ratio 0.99,
95% CI 0.96–1.02), and lower all-cause in-hospital mortality versus those without depression (odds ratio 0.76 (95% CI
0.59–0.97; P=0.028).

Methods: This was a secondary analysis of the Nationwide
Inpatient Sample database, years 2012–2016. Hospitalized
adults aged 18–65 admitted during each influenza season
were included. Depression status was documented via ICD10 codes. The association between depression and clinical
outcomes (e.g., disease severity, length of hospital stay, and
inpatient all-cause mortality) was evaluated using multivariable regression modeling.

Conclusion: This study suggests that in non-elderly hospitalized patients with influenza, depression is associated with
a decreased severity of illness and acute mortality. Chronic
inflammation in those with depression may enhance the ability of the immune response to limit influenza infection or reduce pathologic acute inflammation associated with influenza
disease.

Introduction
Major depression is a well established risk factor for
chronic disease and adverse outcomes in comorbid patients.[1] Among the most studied are the relationships
between depression and increased risk for incident cardiovascular disease [1, 2] and type-2 diabetes.[3, 4]
In comparison, the literature on depression and infectious diseases is less developed. Depression is associated with a significantly increased acquisition of the
common cold [5], Clostridium (Clostridioides) difficile infection following total knee replacement surgery [6],
bloodstream infection [7], enterovirus infection [8], and
is associated with increased risk of infection following
elective shoulder arthroplasty.[9] To date, there is limited evidence of the impact of depression on influenza
illness and outcomes, though a review of the sparse
literature concluded that there is an absence of evi-
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dence to support or refute a link between depression
and risk for influenza acquisition.[10] There is strong
support for an immunologic dysregulation in many patients with depression which could explain some of
these increased risks. Depression-related immune dysregulation is also associated with a blunted response to
vaccines as well as delayed immunity.[11, 12] Patients
with depression have increased pro-inflammatory cytokines (e.g., Interleukin 6, Tumor Necrosis Factor alpha) [13, 14] resulting in release of acute phase proteins, chemokines, and adhesion molecules [15]; immune cell differentiation and recruitment; and a wide
array of other impacts on the human body.[16] Given
depression is associated with a dysregulated immune
state, depressed patients may have a differential disease severity or outcome after infection as well.
Understanding the relationships between depression
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and influenza is critical. Nearly 21% of adults in
the United States will experience a major depressive
episode in their lifetime [17] and depression is now the
leading cause of disability worldwide.[18] Further, influenza results in substantial morbidity and mortality
globally each year and influenza research is often limited to only the elderly population, leaving a dearth
of evidence in non-elderly populations.[19] Further research is warranted to determine if this common mental illness is associated with increased severity of, or
poor outcomes in patients with influenza infection. The
objective of this study was to evaluate the association
between depression and influenza severity and clinical outcomes in non-elderly adult patients hospitalized
with influenza in the United States.

tient’s physiologic decompensation or loss of organ
system function and is calculated through passing diagnosis and procedure codes through a complex multiphase algorithm developed by 3M Health Information
Systems. The APR-DRG severity was dichotomized
into severe (Major or Extreme Loss of Function) versus
non severe (Minor or Moderate Loss of Function).

Methods

The following variables were selected for adjustment in
regression modeling due to their potential confounding
effects: Age (restricted cubic spline with 4 knots), gender, ICD-9/ICD-10 codes for diagnosis of pneumonia,
nicotine dependence, anxiety disorder, and alcohol use
disorder (see Appendix for detailed definitions), APRDRG Severity (for mortality and length of stay models), APR-DRG mortality risk [21], quartile of median
household income of patients zip code of residence,
and 2017 AHRQ Elixhauser Weighted Comorbidity Index.[22]

Study Design
This was a secondary analysis of data from the National
Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research
and Quality. This database contains is a 20% stratified sample of approximately 6–8 million hospital discharges per year.[20]
Subjects: Inclusion/Exclusion Criteria
Inpatient stays of individuals aged 18 -64 with a discharge diagnosis code (ICD-9 or ICD-10) for influenza,
from 2012 through 2016 were included in the analysis.
Data were limited to months during the peak months
of the typical influenza season in the United States
(November through March). Patients without an all patient refined diagnosis related group (APR-DRG) severity or mortality risk subclass were excluded from analysis.
Human Subjects Protection
Because data are de-identified and publicly available
this study is considered exempt from IRB approval.
Variable Definitions
Exposure:
Depression: Patients were classified as having depression if they had an ICD-9/10 code for depression diagnoses on discharge (see the Supplementary Appendix
for detailed codes).
Outcomes:
Severity: Severity of illness was defined using the
all patient refined diagnosis related group (APRDRG) severity measure as documented in the NIS
database.[21] This measure reflects the extent of a paULJRI | https://ir.library.louisville.edu/jri/vol4/iss2/1

Length of stay: Length of stay was defined as the number of days from admission to discharge or death.
Mortality: Mortality was defined as all-cause inpatient
mortality before discharge as documented in the NIS
database.
Covariates

Statistical Analysis
Categorical variables were described with frequencies
and percentages, while continuous variables were described with means and standard deviations or medians with interquartile ranges, as appropriate. Bivariable comparisons between depressed and nondepressed patients were made using Chi-squared or
Fisher’s Exact tests, while independent samples t-tests
or Mann-Whitney U-tests were used to compare differences in continuous variables.
To define the adjusted impact of depression on disease
severity, a multivariable Poisson regression model with
a robust error estimator was used.[23] In this model,
independent variables included: presence of pneumonia, a restricted cubic spline with 4 knots of the patient’s age, nicotine dependence, anxiety disorder, gender, alcohol use disorder, APR-DRG risk of mortality,
the quartile of median household income of the patients zip code of primary residence, and the weighted
version of the grouped Elixhauser Comorbidity Index
using the Agency for Healthcare Research and Quality
(AHRQ) algorithm.[22] To assess the adjusted impact
of depression on length of hospital stay and account for
patients who died before discharge, competing risks regression was used.[24] All variables described above,
as well as the severity of illness (APR-DRG Severity)
were used for adjustment. To assess the impact of depression on in-hospital mortality, a multivariable logistic regression model was used. The same variables
2
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Table 1. Baseline characteristics of adult, non-elderly inpatients with influenza, November–March, 2012–2016 in the United States.

Age, mean±SD
Female gender, n (%)
Pneumonia, n (%)
Nicotine dependence, n (%)
Alcohol use disorder, n (%)
Anxiety, n (%)
APRDRG Severity of Illness, n (%)
Minor loss of function
Moderate loss of function
Major loss of function
Extreme loss of function
APRDRG Risk of Mortality, n (%)
Minor likelihood of death
Moderate likelihood of death
Major likelihood of death
Extreme likelihood of death
Median household income of residential zip code, n (%)
1
2
3
4
Weighted Elixhauser (AHRQ) Index, n (%)
<0
0
1–4
≥5

Depressed n=4,952

Non-depressed n=37,588

P

50.72±10.69
3,286 (66.4)
1,582 (31.9)
2,045 (41.3)
253 (5.1)
2,039 (41.2)

47.41±12.83
20,321 (54.1)
11,818 (31.4)
12,090 (32.2)
1,536 (4.1)
3,500 (9.3)

<0.001
<0.001
0.481
<0.001
0.001
<0.001
<0.001

446 (9.0)
1,756 (35.5)
1,917 (38.7)
833 (16.8)

4,990 (13.3)
14,064 (37.4)
12,370 (32.9)
6,164 (16.4)

1,940 (39.2)
1,260 (25.4)
1,233 (24.9)
519 (10.5)

16,934 (45.1)
8,717 (23.2)
7,834 (20.8)
4,103 (10.9)

1,564 (32.1)
1,286 (26.4)
1,176 (24.2)
842 (17.3)

13,104 (35.7)
9,416 (25.6)
8,069 (22.0)
6,166 (16.8)

2,000 (40.4)
195 (3.9)
562 (11.3)
2,195 (44.3)

5,764 (15.3)
4,205 (11.2)
5,713 (15.2)
21,906 (58.3)

<0.001

<0.001

<0.001

Abbreviations: APRDRG, all patient refined diagnosis related group; AHRQ, Agency for Healthcare Research and Quality; SD, standard deviation.

as documented for the length of stay model were included as covariates. Variance inflation factors, tolerance statistics, and correlation coefficients were used to
evaluate the presence of multicollinearity before all regression modeling. R v3.6.1 (R Foundation for Statistical Computing, Vienna Austria) was used for all analyses.

Results
A total of 42,540 hospitalized adult, non-elderly patients with influenza were included in the analysis;
4,952 (12%) with a diagnosis code for depression and
37,588 (88%) without. Baseline socio-demographic and
clinical features of patients stratified by the presence or
absence of depression diagnosis can be seen in Table 1.
Several statistically significant differences in characteristics were identified between depressed and nondepressed hospitalized non-elderly adults with influenza. Depressed patients were slightly older (mean
age 50.7 (SD ±10.7) years) compared to patients without
depression (mean age 47.4 years (SD ±12.8, P<0.001).
Patients with depression vs. those without were more
likely to be female (66% vs 54%, P<0.001), have nicotine dependence (41% vs 32%, P<0.001), have alcohol
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use disorder (5% vs 4% (P=0.001), and an anxiety disorder (41% vs 9%, p<0.001). Depressed patients had a
decreased unadjusted mortality versus non depressed
patients (1.7% vs 2.7%, P<0.001).
As depicted in Table 2, non-elderly influenza patients with depression were found to have a 3.8% decreased adjusted risk of a major or severe loss of function versus those without depression (95% CI: 1.9%–
5.7%; P<0.001). Table 3 reports the results of competing risks regression for evaluation of adjusted associations between depression and length of hospital
stay. Non-elderly influenza patients with depression
had no change in length of stay (adjusted hazard ratio
of discharge 0.99, 95% CI 0.96–1.02). As depicted in Table 4, non-elderly influenza patients with depression
had lower all-cause in-hospital mortality versus those
without depression (adjusted Odds Ratio=0.76; 95% CI
0.59–0.97; P=0.028).

Discussion
In a large sample of non-elderly hospitalized patients
with influenza infection, those with depression diagnoses had a decreased risk of more severe disease and
a lower odds of inpatient mortality, but showed no dif-
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Table 2. Results of the multivariable regression model for severity of illness for adult, non-elderly inpatients with influenza, November–March,
2012–2016 in the United States.

Variable

Risk ratio

Lower 95% CI

Upper 95% CI

P

Depression
Female gender

0.96
1.00

0.943
0.991

0.981
1.016

<0.001
0.630

Age, spline 1
Age, spline 2
Age, spline 3
Age, spline 4

1.00
1.00
0.99
1.07

0.994
0.992
0.946
0.914

1.001
1.007
1.044
1.245

0.107
0.926
0.802
0.412

Nicotine dependence
Anxiety
Alcohol use disorder
Pneumonia

0.98
0.96
1.00
1.19

0.968
0.947
0.972
1.175

0.994
0.981
1.023
1.206

0.005
<0.001
0.820
<0.001

APR-DRG mortality risk minor
APR-DRG mortality risk moderate
APR-DRG mortality risk major
APR-DRG mortality risk extreme

Reference
4.51
6.96
6.24

4.303
6.651
5.939

4.726
7.291
6.552

<0.001
<0.001
<0.001

Median household income of ZIP code quartile 1
Median household income of ZIP code quartile 2
Median household income of ZIP code quartile 3
Median household income of ZIP code quartile 4

Reference
1.00
1.02
1.02

0.987
1.004
0.997

1.020
1.038
1.035

0.704
0.017
0.104

Weighted Elixhauser (AHRQ) Index <0
Weighted Elixhauser (AHRQ) Index 0
Weighted Elixhauser (AHRQ) Index 1-4
Weighted Elixhauser (AHRQ) Index ≥5

Reference
0.95
0.91
0.97

0.927
0.873
0.942

0.97
0.954
1.000

<0.001
<0.001
0.048

Abbreviations: APRDRG, all patient refined diagnosis related group; AHRQ, Agency for Healthcare Research
and Quality; CI, confidence interval.

ference in length of hospital stay. The relationship between depression and severity of disease was statistically significant, but the magnitude of the association
was small and not likely to be clinically meaningful.
This limited impact could be due to more severe illness in general regardless of depression status as indicated by the need for hospitalization. This magnitudue
may be more pronounced in outpatient settings where
severity of illness may have a wider distribution. It is
also possible that by selecting a younger age cohort, we
have selected for more severe hospitalized influenza
cases.
While the lower risk of mortality in patients with depression is seemingly paradoxical and is in disagreement with one study in the Veterans Health Administration [25], the results may be consistent with the
pathophysiology of influenza mortality. Depression
is known to be associated with immune dysregulation, with many individuals suffering from this condition having increased baseline pro-inflammatory cytokines (e.g., Interleukin-6), and other inflammatory
markers.[13-15, 26] Since death due to influenza is often associated with an overexuberant inflammatory response to infection rather than an overwhelming disseminated infection [27], patients with an already inflamed state may have negative regulatory networks
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activated which protect against excessive increases in
inflammation. This negative feedback may prevent severe immunopathologic responses to influenza infection.[28] As an example, patients with lower respiratory tract infections such as pneumonia (a common
complication of influenza infection) are at increased
risk of myocardial infarction.[29] This is possibly due
to the inflammatory response of the acute respiratory
infection dislodging atherosclerotic plaques, resulting
in infarction. If the inflammatory response post infection is not substantially different from a baseline rate of
inflammation, or this cascade is otherwise influenced
by the baseline inflammation of a patient with depression, this event may not occur, and in-hospital death
rates might be reduced.
Another rationale for our results includes the fact
that depression in the NIS database is administratively coded for reimbursement on discharge. This
means that the disease was significant for care during hospitalization, or was otherwise coded for a
complex case. This may increase the likelihood of
therapy for depression with various other medications, some of which could be anti-inflammatory.[3034] Anti-inflammatory medications may improve the
clinical outcomes of these patients similar to the impact of glucocorticoids, macrolide antibiotics, or other
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Table 3. Results of the multivariable regression model for all-cause inpatient mortality of adult, non-elderly inpatients with influenza, November–
March, 2012–2016 in the United States.

Variable

Hazard ratio

Lower 95% CI

Upper 95% CI

P

0.99
0.97
0.996
0.75
1.05
0.87
0.91

0.961
0.95
0.995
0.639
1.029
0.849
0.896

1.019
0.986
0.996
0.87
1.07
0.897
0.932

0.47
0.001
<0.001
<0.001
0.000
<0.001
<0.001

APR-DRG severity of illness, minor
APR-DRG severity of illness, moderate
APR-DRG severity of illness, major
APR-DRG severity of illness, extreme

Reference
0.81
0.56
0.27

0.782
0.535
0.259

0.832
0.579
0.289

<0.001
<0.001
<0.001

APR-DRG mortality risk minor
APR-DRG mortality risk moderate
APR-DRG mortality risk major
APR-DRG mortality risk extreme

Reference
0.91
0.84
0.46

0.882
0.807
0.434

0.934
0.867
0.483

<0.001
<0.001
<0.001

Median household income of ZIP code quartile 1
Median household income of ZIP code quartile 2
Median household income of ZIP code quartile 3
Median household income of ZIP code quartile 4

Reference
1.05
1.04
1.03

1.023
1.011
1.003

1.072
1.062
1.059

<0.001
0.004
0.031

Weighted Elixhauser (AHRQ) Index <0
Weighted Elixhauser (AHRQ) Index 0
Weighted Elixhauser (AHRQ) Index 1–4
Weighted Elixhauser (AHRQ) Index ≥5

Reference
1.01
1.18
1.1

0.98
1.137
1.067

1.036
1.229
1.138

0.59
<0.001
<0.001

Depression
Female gender
Age
Nicotine dependence
Anxiety
Alcohol use disorder
Pneumonia

Abbreviations: APRDRG, all patient refined diagnosis related group; AHRQ, Agency for Healthcare Research
and Quality; CI, confidence interval.

anti-inflammatory medications in patients with severe
respiratory infection.[30-33] If depressed patients receive more anti-inflammatory medications than nondepressed patients, inpatient mortality could appear
lower. This issue could also inject various confounding
biases that were uncontrolled. It is also possible that
there is a differential threshold for admitting a patient
with depression and our results could be due to unadjusted artifacts of this issue, also similarly described in
patients with obesity.[35]
One aspect not evaluated in this study includes the actual risk of influenza acquisition in the presence or absence of depression. The literature on this topic remains inconsistent and is dominated by small samples, with a systematic review concluding the quality of evidence does not support concluding there is
an increased risk.[10] However, Segerstrom and colleagues revealed evidence that elderly patients with depression had reduced antibody response to multiple
influenza strains compared to those without depression, suggesting a possible increase in risk of influenza
acquisition.[12] In a separate study in 70 elderly participants, depression was associated with having significantly more influenza like symptoms, though this
was no longer significant in multivariable analysis.[36]
Without large prospective studies, this is likely to reULJRI | https://ir.library.louisville.edu/jri/vol4/iss2/1

main an unknown.
This study has several limitations. First, we did not
have information on influenza vaccine history. Receipt
of the influenza vaccine is thought to, at minimum, a
decreased severity of disease even when infected with
influenza.[37] Mental illness has also been associated
with failure to obtain vaccines, as well as decrease the
immune response to some vaccines.[11, 12] Second, we
were not able to include information on laboratory values which may be significant in the identification of
subgroups affected differently by depressive state (e.g.,
cytokines and acute phase proteins). We also did not
have information on the cause of death for these individuals. Although often difficult to ascertain, this information may assist in identifying subgroups affected
differently by depression. Information on the number
of days with respiratory symptoms before admission
was not available in the NIS database. A delay in hospitalization for or with influenza will delay treatment.
Since therapy with oseltamivir is only effective in the
initial days of infection, a delay in seeking treatment
will result in decreased therapeutic effectiveness resulting in potentially altered clinical outcomes.[38] Therefore, if depressed patients had a shorter duration of
symptoms before hospitalization, they may be treated
sooner resulting in improved clinical outcomes. Lack
5
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Table 4. Results of the multivariable regression model for all-cause inpatient mortality of adult, non-elderly inpatients with influenza, November–
March, 2012–2016 in the United States.

Variable

Odds ratio

Lower 95% CI

Upper 95% CI

P

Depression
Female gender

0.76
1.02

0.594
0.892

0.971
1.169

0.028
0.762

Age, spline 1
Age, spline 2
Age, spline 3
Age, spline 4

1.03
0.99
1.06
0.77

0.993
0.91
0.618
0.146

1.065
1.074
1.816
4.048

0.12
0.789
0.835
0.756

Nicotine dependence
Anxiety
Alcohol use disorder
Pneumonia

0.75
0.66
1.17
1.19

0.639
0.525
0.9
1.036

0.87
0.828
1.512
1.368

<0.001
<0.001
0.246
0.014

APR-DRG severity of illness, minor
APR-DRG severity of illness, moderate
APR-DRG severity of illness, major
APR-DRG severity of illness, extreme

Reference
2.08
3.93
22.2

1.061
1.93
10.805

4.072
8.021
45.627

0.033
<0.001
<0.001

APR-DRG mortality risk minor
APR-DRG mortality risk moderate
APR-DRG mortality risk major
APR-DRG mortality risk extreme

Reference
4.85
7.99
38.7

0.643
1.021
4.89

36.64
62.542
306.602

0.126
0.048
0.001

Median household income of ZIP code quartile 1
Median household income of ZIP code quartile 2
Median household income of ZIP code quartile 3
Median household income of ZIP code quartile 4

Reference
0.91
0.91
0.91

0.768
0.761
0.746

1.087
1.09
1.108

0.308
0.308
0.347

Weighted Elixhauser (AHRQ) Index <0
Weighted Elixhauser (AHRQ) Index 0
Weighted Elixhauser (AHRQ) Index 1–4
Weighted Elixhauser (AHRQ) Index ≥5

Reference
2.02
1.33
0.99

1.407
0.737
0.609

2.901
2.394
1.625

<0.001
0.345
0.983

Abbreviations: APRDRG, all patient refined diagnosis related group; AHRQ, Agency for Healthcare Research
and Quality; CI, confidence interval.

of information on anti-inflammatory medications (e.g.,
statins, steroids, etc) further limits the understanding
of the relationship between depression and outcomes
if depression is a result of hyperinflammation. Further,
we did not have information on depression history and
severity, and we lacked data on types of and compliance with treatment received including specific antidepressant medications, anti-psychotics and other psychotropics, some of which have recently been shown
to alter feedback loops with depression (and likely inflammation).[39] Given the reliance on discharge ICD9/10 codes, it is likely patients with depression or other
covariates were misclassified. Our study focused on
a younger age cohort, one typically not evaluated in
studies of influenza and lower respiratory infection.
Similar studies may have different results in elderly
cohorts. However, defining depression in these older
age groups could be challenging in the hospitalized patient. Finally, we did not have information on obesity
status. Obesity is associated with nearly a two-fold increased risk for depression [40] and obesity is significantly more prevalent in those with depression.[41]
This association could influence our results because
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obesity is a known risk factor for severe influenza infection and increased mortality, since the 2009 H1N1 pandemic.[42, 43] Obesity may be an important effect modifier or have substantial interaction effects with depression due to the well-studied immune dysregulation in
these patients.[28, 35]
There are many areas of research that are needed in
the field of depression and influenza infection. Larger
databases with more complete and precise covariates needed for adjustment (e.g., influenza vaccination
history, other comorbid conditions, anti-inflammatory
medications, obesity) will be necessary to more fully
document these potential associations. Although secondary analytics will continue to uncover clues into
the relationships between this debilitating disease with
risk of and outcomes of infection, prospective studies are needed. For example, understanding the baseline inflammation of individuals prior to infection using novel causal machine learning models [44] may result in targeted approaches to influenza prevention and
management. Associations between intestinal or respiratory microbiota, depression, and infection may also
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be warranted to define other novel areas for therapy.
Recently, changes in the gut microbiota have been documented in patients with depression [45], though the
directional impact is still unknown. Regardless, intestinal microbiota dysregulation increases systemic inflammation, and depression is preceded by systemic inflammation in some patients.[46-48] If gut microbiota
induced systemic inflammation can trigger mood disorders, modulation of the gut microbiota may play
a role in depression therapy and prevention of infec-

tion.[39]
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